arsenic trioxide has been researched along with Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benitez, L; Clemons, B; Cox, J; Griffin, S; Hickey, E; Ramlal, R; Sutphin, S | 1 |
| Alvarez-Guaita, A; Buechler, C; Eisinger, K; Enrich, C; Grewal, T; Haberl, EM; Krautbauer, S; Neumeier, M; Pohl, R; Rein-Fischboeck, L; Rentero, C | 1 |
2 other study(ies) available for arsenic trioxide and Obesity
| Article | Year |
|---|---|
Multicenter evaluation of arsenic trioxide dosing in obese patients with low-intermediate risk acute promyelocytic leukemia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Arsenic Trioxide; Female; Follow-Up Studies; Humans; Leukemia, Promyelocytic, Acute; Long QT Syndrome; Male; Middle Aged; Obesity; Prognosis; Retrospective Studies; Young Adult | 2019 |
Annexin A6 regulates adipocyte lipid storage and adiponectin release.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; Adiponectin; Animals; Annexin A6; Arsenic Trioxide; Arsenicals; Chemokines; Fatty Acids; Gene Knockdown Techniques; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Insulin; Intercellular Signaling Peptides and Proteins; Intra-Abdominal Fat; Lipid Droplets; Lipid Metabolism; Lipolysis; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Oxides; Signal Transduction; Triglycerides | 2017 |